Literature DB >> 3178027

Prevalence and specificity of antibodies to bovine respiratory syncytial virus in sera from feedlot and range cattle.

J K Collins1, R M Teegarden, D W MacVean, G H Smith, G R Frank.   

Abstract

The specificity of serum antibodies for the polypeptides of bovine respiratory syncytial virus (BRSV) was examined, using sera obtained from feedlot and range cattle. Test results in sera from feedlot cattle indicated a 60% rate of seroconversion and 95% seropositivity to BRSV, associated with lack of clinical signs indicative of respiratory tract disease. Exposure to other common respiratory tract viruses also was high (greater than or equal to 92% to bovine herpesvirus type 1, bovine viral diarrhea virus, and para-influenza virus type 3). Test results in sera from range cattle indicated BRSV seropositive rates of 28% in calves, 49% in yearling cattle, and 70% in mature cows; clinical signs of respiratory tract disease were not observed in these cattle. Antibodies to BRSV in sera from cattle in both environments reacted predominantly with polypeptides of molecular weight 80,000 through 85,000, 40,000, and 28,000. Reactivity to a glycoprotein of molecular weight between 43,000 and 44,000 and to several glycopolypeptides of smaller molecular weight increased in serum specimens obtained from feedlot cattle between time of entry into the feedlot and slaughter.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178027

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Monoclonal antibodies to the fusion protein of bovine respiratory syncytial virus.

Authors:  K M Mulkey; G A Anderson
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

2.  Comparison of caprine, human and bovine strains of respiratory syncytial virus.

Authors:  M Trudel; F Nadon; C Simard; F Bélanger; R Alain; C Séguin; G Lussier
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.

Authors:  Ulrike Schmidt; Jörg Beyer; Ulf Polster; Laurel J Gershwin; Ursula J Buchholz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  The associations of viral and mycoplasmal antibody titers with respiratory disease and weight gain in feedlot calves.

Authors:  S W Martin; E Nagy; D Armstrong; S Rosendal
Journal:  Can Vet J       Date:  1999-08       Impact factor: 1.008

5.  Analysis of polypeptides synthesized in bovine respiratory syncytial virus-infected cells.

Authors:  S K Mallipeddi; S K Samal; S B Mohanty
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Identifying bovine respiratory syncytial virus by reverse transcription-polymerase chain reaction and oligonucleotide hybridizations.

Authors:  R D Oberst; M P Hays; K J Hennessy; L C Stine; J F Evermann; C L Kelling
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

Review 7.  A Review of UK-Registered and Candidate Vaccines for Bovine Respiratory Disease.

Authors:  Joanne L Lemon; Michael J McMenamy
Journal:  Vaccines (Basel)       Date:  2021-11-27

Review 8.  Epidemiology, molecular epidemiology and evolution of bovine respiratory syncytial virus.

Authors:  Rosa Elena Sarmiento-Silva; Yuko Nakamura-Lopez; Gilberto Vaughan
Journal:  Viruses       Date:  2012-11-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.